Stock RSPI RESPIRERX PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart RespireRx Pharmaceuticals Inc.

Equities

RSPI

US7612273059

Delayed OTC Markets
Other stock markets
 10:21:28 2024-06-06 am EDT 		5-day change 1st Jan Change
0.0025 USD +2.04% Intraday chart for RespireRx Pharmaceuticals Inc. -26.47% +177.78%
Apr. 10 RespireRx Pharmaceuticals Inc. announced that it has received $0.1 million in funding CI
Mar. 20 RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
RESPIRERX PHARMACEUTICALS INC.
Bio Therapeutic Drugs
+2.04%-26.47%+177.78%-24.24%-99.96% 1.97M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. RSPI Stock
  4. Charts RespireRx Pharmaceuticals Inc.
  5. Comparison Chart